HEOR News
Characterizing Health Plan Evidence Review Practices (Academy of Managed Care Pharmacy)
Health plans tend to update their coverage policies over a 2-year period, researchers found, and in these updates they more comprehensively cite health technology assessments, randomized controlled trials, and systematic reviews/meta-analyses.
Read more
6 Years After Initial Pledge, Califf Launches Another FDA Program to Study the Opioid Crisis (Fierce Pharma)
In his second tenure as Commissioner of the US Food and Drug Administration, Robert Califf is once again calling for examination of the opioid crisis, with the agency trying to determine what’s needed to support appropriate use of painkillers.
Read more
China’s Strict Zero-COVID Measures Take a Large-Scale Toll on Youth Mental Health (South China Morning Post)
Experts predict that the impact of the strict lockdowns and other measures to combat COVID-19 will affect Chinese youth for years.
Read more
Costs Cast Cloud Over Nigeria’s HPV Vaccine Plan (SciDevNet)
Nigeria intends to start vaccination against cervical cancer by May 2023, but the cost of the vaccine may derail those plans once more.
Read more
African Health Ministers Adopt New Regional Strategy to Transform Health Security (WHO)
African health ministers have adopted a new 8-year strategy to transform health security and emergency response in the region, with the goal of reducing the health and socioeconomic impacts of public health emergencies such as the COVID-19 pandemic.
Read more
Unraveling the Interplay of Omicron, Reinfections, and Long COVID (Kaiser Health News)
While hospitalizations and cases from Omicron infection are falling, experts are still trying to determine if the variant causes symptoms of long COVID as often or as severe as previous variants.
Read more
ICER Publishes Evidence Report on Treatments for Amyotrophic Lateral Sclerosis (ICER)
ICER evaluated AMX0035 and edaravone, finding the former comparable or better to standard of care and stating that it would be cost-effective priced at between $9100 and $30,600 per year. The group found edaravone comparable or incrementally better to standard of care and most cost-effective if priced between $1400 and $3200 per year.
Read more
African Health Ministers Endorse New Strategy to Curb Chronic Disease Crisis (WHO)
With the increasing burden of cardiovascular disease, mental and neurological disorders, and diabetes in the region, African health ministers are trying to expand access to treatments.
Read more
French Doctolib Platform Accused of ‘Promoting Alternative Medicine’ (The Connexion)
France’s medical appointment booking site allegedly offered appointments with naturopaths and other nonaccredited practitioners.
Read more
Japanese Government Steps Up Efforts to Care for Women Who Miscarry (The Japan Times)
Municipalities in Japan are promoting mental health programs for women who miscarry, backed by the Ministry of Health, Labor, and Welfare’s handbook compiled by a research team of experts for use by local governments and medical institutions.
Read more
